{
    "organizations": [],
    "uuid": "28a1e1bab57f034dea4a5b86a00bebc32f6a7041",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-diamyd-medical-shows-continued-pos/brief-diamyd-medical-shows-continued-positive-clinical-course-for-diabetes-vaccine-idUSFWN1P202B",
    "ord_in_thread": 0,
    "title": "BRIEF-Diamyd Medical Shows Continued Positive Clinical Course For Diabetes Vaccine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Diamyd Medical Ab:\n* THE DIABETES VACCINE DIAMYD® SHOWS CONTINUED POSITIVE CLINICAL COURSE AFTER 30 MONTHS\n* ‍DATA INDICATE THAT DISEASE PROGRESSION IS STILL POSITIVE AT 30 MONTHS FOR THESE FIRST FOUR PATIENTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-08T15:58:00.000+02:00",
    "crawled": "2018-01-09T16:59:53.046+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "diamyd",
        "medical",
        "ab",
        "diabetes",
        "vaccine",
        "show",
        "continued",
        "positive",
        "clinical",
        "course",
        "month",
        "indicate",
        "disease",
        "progression",
        "still",
        "positive",
        "month",
        "first",
        "four",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}